Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Advertisers
    • Editorial Board
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Cancer Genomics & Proteomics
    • Anticancer Research
    • In Vivo

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Cancer Genomics & Proteomics
  • Other Publications
    • Cancer Genomics & Proteomics
    • Anticancer Research
    • In Vivo
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Cancer Genomics & Proteomics

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Advertisers
    • Editorial Board
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Visit iiar on Facebook
  • Follow us on Linkedin

Table of Contents

March-April 2012; Volume 9,Issue 2
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

B

  1. Bao, Channa

    1. You have access
      Preclinical Rationale for Combining an EGFR Antibody with Cisplatin/Gemcitabine for the Treatment of NSCLC
      Selda Samakoglu, Dhanvanthri S. Deevi, Huiling Li, Su Wang, Mary Murphy, Channa Bao, Rajiv Bassi, Marie Prewett and James R. Tonra
      Cancer Genomics & Proteomics March 2012, 9 (2) 77-92;
  2. Bassi, Rajiv

    1. You have access
      Preclinical Rationale for Combining an EGFR Antibody with Cisplatin/Gemcitabine for the Treatment of NSCLC
      Selda Samakoglu, Dhanvanthri S. Deevi, Huiling Li, Su Wang, Mary Murphy, Channa Bao, Rajiv Bassi, Marie Prewett and James R. Tonra
      Cancer Genomics & Proteomics March 2012, 9 (2) 77-92;
  3. Bougnoux, AC.

    1. You have access
      Proteomic Analysis of Differently Archived Breast Cancer Tissues
      AC. Bougnoux, A. Mange and J. Solassol
      Cancer Genomics & Proteomics March 2012, 9 (2) 93-99;
  4. Buon, Leutz

    1. You have access
      Targeting PI3K and RAD51 in Barrett’s Adenocarcinoma: Impact on DNA Damage Checkpoints, Expression Profile and Tumor Growth
      Jagannath Pal, Mariateresa Fulciniti, Puru Nanjappa, Leutz Buon, Yu-Tzu Tai, Pierfrancesco Tassone, Nikhil C. Munshi and Masood A. Shammas
      Cancer Genomics & Proteomics March 2012, 9 (2) 55-66;

C

  1. Chan, Jason

    1. You have access
      Proteomic Identification of Chaperonin-containing Tail-less Complex Polypeptide-1 Gamma Subunit as a p53-responsive Protein in Colon Cancer Cells
      Shao Chin Lee and Jason Chan
      Cancer Genomics & Proteomics March 2012, 9 (2) 101-108;

D

  1. Deevi, Dhanvanthri S.

    1. You have access
      Preclinical Rationale for Combining an EGFR Antibody with Cisplatin/Gemcitabine for the Treatment of NSCLC
      Selda Samakoglu, Dhanvanthri S. Deevi, Huiling Li, Su Wang, Mary Murphy, Channa Bao, Rajiv Bassi, Marie Prewett and James R. Tonra
      Cancer Genomics & Proteomics March 2012, 9 (2) 77-92;

F

  1. Fulciniti, Mariateresa

    1. You have access
      Targeting PI3K and RAD51 in Barrett’s Adenocarcinoma: Impact on DNA Damage Checkpoints, Expression Profile and Tumor Growth
      Jagannath Pal, Mariateresa Fulciniti, Puru Nanjappa, Leutz Buon, Yu-Tzu Tai, Pierfrancesco Tassone, Nikhil C. Munshi and Masood A. Shammas
      Cancer Genomics & Proteomics March 2012, 9 (2) 55-66;

I

  1. Iida, Satoru

    1. You have access
      Screening for Epigenetically Masked Genes in Colorectal Cancer Using 5-Aza-2’-deoxycytidine, Microarray and Gene Expression Profile
      Ahmed Khamas, Toshiaki Ishikawa, Kazuro Shimokawa, Kaoru Mogushi, Satoru Iida, Megumi Ishiguro, Hiroshi Mizushima, Hiroshi Tanaka, Hiroyuki Uetake and Kenichi Sugihara
      Cancer Genomics & Proteomics March 2012, 9 (2) 67-75;
  2. Ishiguro, Megumi

    1. You have access
      Screening for Epigenetically Masked Genes in Colorectal Cancer Using 5-Aza-2’-deoxycytidine, Microarray and Gene Expression Profile
      Ahmed Khamas, Toshiaki Ishikawa, Kazuro Shimokawa, Kaoru Mogushi, Satoru Iida, Megumi Ishiguro, Hiroshi Mizushima, Hiroshi Tanaka, Hiroyuki Uetake and Kenichi Sugihara
      Cancer Genomics & Proteomics March 2012, 9 (2) 67-75;
  3. Ishikawa, Toshiaki

    1. You have access
      Screening for Epigenetically Masked Genes in Colorectal Cancer Using 5-Aza-2’-deoxycytidine, Microarray and Gene Expression Profile
      Ahmed Khamas, Toshiaki Ishikawa, Kazuro Shimokawa, Kaoru Mogushi, Satoru Iida, Megumi Ishiguro, Hiroshi Mizushima, Hiroshi Tanaka, Hiroyuki Uetake and Kenichi Sugihara
      Cancer Genomics & Proteomics March 2012, 9 (2) 67-75;

K

  1. Khamas, Ahmed

    1. You have access
      Screening for Epigenetically Masked Genes in Colorectal Cancer Using 5-Aza-2’-deoxycytidine, Microarray and Gene Expression Profile
      Ahmed Khamas, Toshiaki Ishikawa, Kazuro Shimokawa, Kaoru Mogushi, Satoru Iida, Megumi Ishiguro, Hiroshi Mizushima, Hiroshi Tanaka, Hiroyuki Uetake and Kenichi Sugihara
      Cancer Genomics & Proteomics March 2012, 9 (2) 67-75;

L

  1. Lee, Shao Chin

    1. You have access
      Proteomic Identification of Chaperonin-containing Tail-less Complex Polypeptide-1 Gamma Subunit as a p53-responsive Protein in Colon Cancer Cells
      Shao Chin Lee and Jason Chan
      Cancer Genomics & Proteomics March 2012, 9 (2) 101-108;
  2. Li, Huiling

    1. You have access
      Preclinical Rationale for Combining an EGFR Antibody with Cisplatin/Gemcitabine for the Treatment of NSCLC
      Selda Samakoglu, Dhanvanthri S. Deevi, Huiling Li, Su Wang, Mary Murphy, Channa Bao, Rajiv Bassi, Marie Prewett and James R. Tonra
      Cancer Genomics & Proteomics March 2012, 9 (2) 77-92;

M

  1. Mange, A.

    1. You have access
      Proteomic Analysis of Differently Archived Breast Cancer Tissues
      AC. Bougnoux, A. Mange and J. Solassol
      Cancer Genomics & Proteomics March 2012, 9 (2) 93-99;
  2. Mizushima, Hiroshi

    1. You have access
      Screening for Epigenetically Masked Genes in Colorectal Cancer Using 5-Aza-2’-deoxycytidine, Microarray and Gene Expression Profile
      Ahmed Khamas, Toshiaki Ishikawa, Kazuro Shimokawa, Kaoru Mogushi, Satoru Iida, Megumi Ishiguro, Hiroshi Mizushima, Hiroshi Tanaka, Hiroyuki Uetake and Kenichi Sugihara
      Cancer Genomics & Proteomics March 2012, 9 (2) 67-75;
  3. Mogushi, Kaoru

    1. You have access
      Screening for Epigenetically Masked Genes in Colorectal Cancer Using 5-Aza-2’-deoxycytidine, Microarray and Gene Expression Profile
      Ahmed Khamas, Toshiaki Ishikawa, Kazuro Shimokawa, Kaoru Mogushi, Satoru Iida, Megumi Ishiguro, Hiroshi Mizushima, Hiroshi Tanaka, Hiroyuki Uetake and Kenichi Sugihara
      Cancer Genomics & Proteomics March 2012, 9 (2) 67-75;
  4. Munshi, Nikhil C.

    1. You have access
      Targeting PI3K and RAD51 in Barrett’s Adenocarcinoma: Impact on DNA Damage Checkpoints, Expression Profile and Tumor Growth
      Jagannath Pal, Mariateresa Fulciniti, Puru Nanjappa, Leutz Buon, Yu-Tzu Tai, Pierfrancesco Tassone, Nikhil C. Munshi and Masood A. Shammas
      Cancer Genomics & Proteomics March 2012, 9 (2) 55-66;
  5. Murphy, Mary

    1. You have access
      Preclinical Rationale for Combining an EGFR Antibody with Cisplatin/Gemcitabine for the Treatment of NSCLC
      Selda Samakoglu, Dhanvanthri S. Deevi, Huiling Li, Su Wang, Mary Murphy, Channa Bao, Rajiv Bassi, Marie Prewett and James R. Tonra
      Cancer Genomics & Proteomics March 2012, 9 (2) 77-92;

N

  1. Nanjappa, Puru

    1. You have access
      Targeting PI3K and RAD51 in Barrett’s Adenocarcinoma: Impact on DNA Damage Checkpoints, Expression Profile and Tumor Growth
      Jagannath Pal, Mariateresa Fulciniti, Puru Nanjappa, Leutz Buon, Yu-Tzu Tai, Pierfrancesco Tassone, Nikhil C. Munshi and Masood A. Shammas
      Cancer Genomics & Proteomics March 2012, 9 (2) 55-66;

P

  1. Pal, Jagannath

    1. You have access
      Targeting PI3K and RAD51 in Barrett’s Adenocarcinoma: Impact on DNA Damage Checkpoints, Expression Profile and Tumor Growth
      Jagannath Pal, Mariateresa Fulciniti, Puru Nanjappa, Leutz Buon, Yu-Tzu Tai, Pierfrancesco Tassone, Nikhil C. Munshi and Masood A. Shammas
      Cancer Genomics & Proteomics March 2012, 9 (2) 55-66;
  2. Prewett, Marie

    1. You have access
      Preclinical Rationale for Combining an EGFR Antibody with Cisplatin/Gemcitabine for the Treatment of NSCLC
      Selda Samakoglu, Dhanvanthri S. Deevi, Huiling Li, Su Wang, Mary Murphy, Channa Bao, Rajiv Bassi, Marie Prewett and James R. Tonra
      Cancer Genomics & Proteomics March 2012, 9 (2) 77-92;

S

  1. Samakoglu, Selda

    1. You have access
      Preclinical Rationale for Combining an EGFR Antibody with Cisplatin/Gemcitabine for the Treatment of NSCLC
      Selda Samakoglu, Dhanvanthri S. Deevi, Huiling Li, Su Wang, Mary Murphy, Channa Bao, Rajiv Bassi, Marie Prewett and James R. Tonra
      Cancer Genomics & Proteomics March 2012, 9 (2) 77-92;
  2. Shammas, Masood A.

    1. You have access
      Targeting PI3K and RAD51 in Barrett’s Adenocarcinoma: Impact on DNA Damage Checkpoints, Expression Profile and Tumor Growth
      Jagannath Pal, Mariateresa Fulciniti, Puru Nanjappa, Leutz Buon, Yu-Tzu Tai, Pierfrancesco Tassone, Nikhil C. Munshi and Masood A. Shammas
      Cancer Genomics & Proteomics March 2012, 9 (2) 55-66;
  3. Shimokawa, Kazuro

    1. You have access
      Screening for Epigenetically Masked Genes in Colorectal Cancer Using 5-Aza-2’-deoxycytidine, Microarray and Gene Expression Profile
      Ahmed Khamas, Toshiaki Ishikawa, Kazuro Shimokawa, Kaoru Mogushi, Satoru Iida, Megumi Ishiguro, Hiroshi Mizushima, Hiroshi Tanaka, Hiroyuki Uetake and Kenichi Sugihara
      Cancer Genomics & Proteomics March 2012, 9 (2) 67-75;
  4. Solassol, J.

    1. You have access
      Proteomic Analysis of Differently Archived Breast Cancer Tissues
      AC. Bougnoux, A. Mange and J. Solassol
      Cancer Genomics & Proteomics March 2012, 9 (2) 93-99;
  5. Sugihara, Kenichi

    1. You have access
      Screening for Epigenetically Masked Genes in Colorectal Cancer Using 5-Aza-2’-deoxycytidine, Microarray and Gene Expression Profile
      Ahmed Khamas, Toshiaki Ishikawa, Kazuro Shimokawa, Kaoru Mogushi, Satoru Iida, Megumi Ishiguro, Hiroshi Mizushima, Hiroshi Tanaka, Hiroyuki Uetake and Kenichi Sugihara
      Cancer Genomics & Proteomics March 2012, 9 (2) 67-75;

T

  1. Tai, Yu-Tzu

    1. You have access
      Targeting PI3K and RAD51 in Barrett’s Adenocarcinoma: Impact on DNA Damage Checkpoints, Expression Profile and Tumor Growth
      Jagannath Pal, Mariateresa Fulciniti, Puru Nanjappa, Leutz Buon, Yu-Tzu Tai, Pierfrancesco Tassone, Nikhil C. Munshi and Masood A. Shammas
      Cancer Genomics & Proteomics March 2012, 9 (2) 55-66;
  2. Tanaka, Hiroshi

    1. You have access
      Screening for Epigenetically Masked Genes in Colorectal Cancer Using 5-Aza-2’-deoxycytidine, Microarray and Gene Expression Profile
      Ahmed Khamas, Toshiaki Ishikawa, Kazuro Shimokawa, Kaoru Mogushi, Satoru Iida, Megumi Ishiguro, Hiroshi Mizushima, Hiroshi Tanaka, Hiroyuki Uetake and Kenichi Sugihara
      Cancer Genomics & Proteomics March 2012, 9 (2) 67-75;
  3. Tassone, Pierfrancesco

    1. You have access
      Targeting PI3K and RAD51 in Barrett’s Adenocarcinoma: Impact on DNA Damage Checkpoints, Expression Profile and Tumor Growth
      Jagannath Pal, Mariateresa Fulciniti, Puru Nanjappa, Leutz Buon, Yu-Tzu Tai, Pierfrancesco Tassone, Nikhil C. Munshi and Masood A. Shammas
      Cancer Genomics & Proteomics March 2012, 9 (2) 55-66;
  4. Tonra, James R.

    1. You have access
      Preclinical Rationale for Combining an EGFR Antibody with Cisplatin/Gemcitabine for the Treatment of NSCLC
      Selda Samakoglu, Dhanvanthri S. Deevi, Huiling Li, Su Wang, Mary Murphy, Channa Bao, Rajiv Bassi, Marie Prewett and James R. Tonra
      Cancer Genomics & Proteomics March 2012, 9 (2) 77-92;

U

  1. Uetake, Hiroyuki

    1. You have access
      Screening for Epigenetically Masked Genes in Colorectal Cancer Using 5-Aza-2’-deoxycytidine, Microarray and Gene Expression Profile
      Ahmed Khamas, Toshiaki Ishikawa, Kazuro Shimokawa, Kaoru Mogushi, Satoru Iida, Megumi Ishiguro, Hiroshi Mizushima, Hiroshi Tanaka, Hiroyuki Uetake and Kenichi Sugihara
      Cancer Genomics & Proteomics March 2012, 9 (2) 67-75;

W

  1. Wang, Su

    1. You have access
      Preclinical Rationale for Combining an EGFR Antibody with Cisplatin/Gemcitabine for the Treatment of NSCLC
      Selda Samakoglu, Dhanvanthri S. Deevi, Huiling Li, Su Wang, Mary Murphy, Channa Bao, Rajiv Bassi, Marie Prewett and James R. Tonra
      Cancer Genomics & Proteomics March 2012, 9 (2) 77-92;
Back to top
PreviousNext

In this issue

Cancer Genomics - Proteomics: 9 (2)
Cancer Genomics & Proteomics
Vol. 9, Issue 2
March-April 2012
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Top Topics
  • Most Cited
  • Most Read
Loading
Breast Cancer Metastasis
Applications of Support Vector Machine (SVM) Learning in Cancer Genomics
Cancer-related Issues of CD147
Long Non-coding RNAs and their Role in Metastasis
The Multiple Roles of Exosomes in Metastasis
Screening for Epigenetically Masked Genes in Colorectal Cancer Using 5-Aza-2’-deoxycytidine, Microarray and Gene Expression Profile
Cancer & Genome Proteomics

© 2022 Cancer Genomics & Proteomics

Powered by HighWire